Reuters logo
BRIEF-Cesca Therapeutics says ‍entered into amendment no.1 to revolving credit agreement with Boyalife Investment Fund II
September 19, 2017 / 10:56 AM / 3 months ago

BRIEF-Cesca Therapeutics says ‍entered into amendment no.1 to revolving credit agreement with Boyalife Investment Fund II

Sept 19 (Reuters) - Cesca Therapeutics Inc:

* Cesca Therapeutics Inc says ‍entered into an amendment no. 1 to revolving credit agreement with Boyalife Investment Fund II, Inc. - SEC filing​

* Cesca Therapeutics - on September 13, 2017 co entered into an amendment no. 1 to revolving credit agreement with Boyalife Investment Fund II, Inc

* Cesca Therapeutics Inc -amended credit agreement​ ‍increasing company’s maximum borrowing availability thereunder from $5.0 million to $10.0 million

* Cesca Therapeutics Inc - amended credit agreement amends revolving credit agreement originally entered into by company and lender on March 6, 2017

* Cesca Therapeutics- co, lender entered into an amended and restated convertible promissory note to reflect new maximum principal amount of $10.0 million Source text: (bit.ly/2wDpRC0) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below